Simultaneous RP-HPLC Method for Estimation of Ezetimibe and Simvastatin in Bulk and Dosage Forms
R Siva Kumar, Santhanakrishnan, P. Kumar Nallasivan, R Venkatanarayanan
Abstract
R Siva Kumar, Santhanakrishnan, P. Kumar Nallasivan, R Venkatanarayanan
Abstract
A simple, specific, accurate, precise, rapid and reproducible reverse HPLC method has been developed for the simultaneous estimation of ezetimibe and simvastatin in bulk and tablet dosage forms using C18 column (symmetry, 4.6 mm x 25 cm) in isocratic mode with methanol: water (95:05 v/v) as a mobile phase with the detection wavelength of 248 nm and the flow rate was 0.8 ml/min. The retention time of ezetimibe and simvastatin was found to 3.2 min and be 4.9 min, respectively. Linearity of the ezetimibe and simvastatin was found in the range of 5–70 μg/ml and 5–50 μg/ml, respectively. The recoveries of ezetimibe and simvastatin were found to be in the range of 99.27–101.10% and 99.63100.50%, respectively. The proposed method was validated suitably and can be used for routine analysis.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A simple, specific, accurate, precise, rapid and reproducible reverse HPLC method has been developed for the simultaneous estimation of ezetimibe and simvastatin in bulk and tablet dosage forms using C18 column (symmetry, 4.6 mm x 25 cm) in isocratic mode with methanol: water (95:05 v/v) as a mobile phase with the detection wavelength of 248 nm and the flow rate was 0.8 ml/min. The retention time of ezetimibe and simvastatin was found to 3.2 min and be 4.9 min, respectively. Linearity of the ezetimibe and simvastatin was found in the range of 5–70 μg/ml and 5–50 μg/ml, respectively. The recoveries of ezetimibe and simvastatin were found to be in the range of 99.27–101.10% and 99.63100.50%, respectively. The proposed method was validated suitably and can be used for routine analysis.
Key concepts: Ezetimibe, Simvastatin, Chromatography, Dosage form, High-performance liquid chromatography, Methanol, Retention time, Chemistry